iwCLL 2019 | Frontline therapies for treatment naive CLL patients

Danielle Brander

Danielle Brander, MD, Duke University School of Medicine, Durham, NC, summarises therapies, practices and trials for frontline treatment of treatment naive CLL (chronic lymphocytic leukemia) patients at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video